Fly Amanita

Fly Amanita

Created using Figma
For the last 3 years Fly Amanita has produced and sold dried Amanita Muscaria (aka Fly Agaric) mushrooms worldwide. Their experience in this fungus market has disclosed two new business opportunities - pharmaceutics demand for chemical compounds such as Muscimol, Ibotenic acid, and Muscarine, and possible rehabilitation applications in healthcare. Consequently, Fly Amanita aims to produce and meet the demand for these compounds that can be extracted for the Amanita Muscaria mushrooms.
The company is also determined to invest in the research of Amanita Muscaria related healthcare applications for rehabilitation of chronic pain, insomnia, menstrual pain, post-traumatic stress, lack of confidence, self-esteem, productivity, depression, and many more. Once those applications are found Fly Amanita plans to establish the first rehabilitation center in the EU for such treatments.
26 apr. 2021
31 mei 2021
100% voltooid
Opgehaald geld - geen gegevens
Doel 500 000.00 USD
pet 500 000.00 USD
past
Details token
Ticker
FLY
Totale voorraad
10000000
Geaccepteerde valuta's
BTC, BNB, EUR, USDT
Min. Bijdrage
50
DOLLAR
Bedrijfsgegevens
Geregistreerde bedrijfsnaam
Fly Amanita
Geregistreerd land
Lithuania
Bedrijf opgericht
Apr 14, 2021
aanvullende details
Platform
BInance Smart Chain
Categorieën
Platform

Over Fly Amanita

Welcome to our online amanita muscaria shop.

We're a family that LOVES Amanita and wants to share the goodness and powerful healing properties of the shroom with the rest of the world. We're truly passionate about what we do because we know it can make a big difference to some people. Picking the mushrooms, drying them, storing them and even using it - we do everything ourselves. We've spent 4 years of studying multiple language literature and made hundreds of experiments to become experts in the field. Our conscious foraging process, immediate drying and safe storage guarantee a product with excellent colour, strong smell, and good taste. Amanita Muscaria has a lot of variations and we're proud to say that we offer 6 of them in our store.

Our priority is to have the best product, educate people about Amanita Muscaria and help those, who need help with this natural remedy

% naam% Roadmap

  • Q2 2021

  • Private sales.
    Public sales. 3 rounds.
  • Q2 - Q3 2021

  • Integrate FLY payments to the Fly Amanita e-shop.
  • Q3 - Q4 2021

  • Start producing and selling chemical compounds (Muscimol, Ibotenic acid and Muscarine) to the pharmaceutical market.
    List FLY in staking projects (there's already a secured deal for that with Bitlocus exchange).
  • Q1 - Q2 2022

  • Assemble a team of experts and volunteers.
    Conduct extensive research and tests for Amanita Muscaria's application in healthcare.
  • Lees verder
  • Milestone 3 (Application & Rehab center)

  • Date TBA (depends on research results) - start offline and online supervisory healing application service.
    Date TBA - establish a rehabilitation center (in Lithuania, EU).

Fly Amanita Team

geverifieerd 0%

Aandacht. Het risico bestaat dat niet-geverifieerde leden feitelijk geen lid zijn van het team

Arunas Siuksteris
CEO
geverifieerde
Jurgita Mitkeviciene
Production Manager
geverifieerde
Guste Gikaraite
Business Development Manager
geverifieerde
Tadas Varanauskas
Blockchain Developer
geverifieerde

Advisors

geverifieerd 25%

Aandacht. Het risico bestaat dat niet-geverifieerde leden feitelijk geen lid zijn van het team

Baiba Baika
Advisor
geverifieerde

12 ICOs

$52 209 956

Arturas Svirskis
Advisor
geverifieerd

29 ICOs

$5 754 875

Timo Trippler
Advisor
geverifieerde
Mofassair Hossain
Advisor
geverifieerde

Fly Amanita Interviews

Arturas Svirskis
As a team member, сan you tell us about your role in the ICO project?
I am responsible with fundraising activities and overall consultancy how to optimize processes in marketing and business development
What do you think about idea?
This idea is not typical for the crypto space, but many crypto investors can benefit out of it by making money

Fly Amanita Laatste nieuws

  • Omdat er mogelijk tijdsverschillen zijn in informatie-updates, moet nauwkeurige informatie over elk ICO-project worden geverifieerd via de officiële website of andere communicatiekanalen.
  • Deze informatie is geen suggestie of advies over beleggen in ICO-financiering. Onderzoek de relevante informatie zelf grondig en besluit over ICO-deelname.
  • Als u denkt dat er problemen of problemen zijn die moeten worden gecorrigeerd voor deze inhoud, of als u uw eigen ICO-project wilt indienen dat wordt vermeld, e-mail ons.
Lees de disclaimer en risicowaarschuwing. Laat disclaimer en risicowaarschuwing zien.